Cargando…
Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270225/ https://www.ncbi.nlm.nih.gov/pubmed/34251893 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.054034 |
| _version_ | 1783720757967192064 |
|---|---|
| author | Felker, G. Michael Butler, Javed Ibrahim, Nasiren E. Piña, Ileana L. Maisel, Alan Bapat, Devavrat Camacho, Alexander Ward, Jonathan H. Williamson, Kristin M. Solomon, Scott D. Januzzi, James L. |
| author_facet | Felker, G. Michael Butler, Javed Ibrahim, Nasiren E. Piña, Ileana L. Maisel, Alan Bapat, Devavrat Camacho, Alexander Ward, Jonathan H. Williamson, Kristin M. Solomon, Scott D. Januzzi, James L. |
| author_sort | Felker, G. Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8270225 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82702252021-07-12 Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF Felker, G. Michael Butler, Javed Ibrahim, Nasiren E. Piña, Ileana L. Maisel, Alan Bapat, Devavrat Camacho, Alexander Ward, Jonathan H. Williamson, Kristin M. Solomon, Scott D. Januzzi, James L. Circulation Correspondence Lippincott Williams & Wilkins 2021-07-13 2021-07-13 /pmc/articles/PMC8270225/ /pubmed/34251893 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.054034 Text en © 2021 The Authors. https://creativecommons.org/licenses/by-nc-nd/4.0/Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Correspondence Felker, G. Michael Butler, Javed Ibrahim, Nasiren E. Piña, Ileana L. Maisel, Alan Bapat, Devavrat Camacho, Alexander Ward, Jonathan H. Williamson, Kristin M. Solomon, Scott D. Januzzi, James L. Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF |
| title | Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF |
| title_full | Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF |
| title_fullStr | Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF |
| title_full_unstemmed | Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF |
| title_short | Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF |
| title_sort | implantable cardioverter-defibrillator eligibility after initiation of sacubitril/valsartan in chronic heart failure: insights from prove-hf |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270225/ https://www.ncbi.nlm.nih.gov/pubmed/34251893 http://dx.doi.org/10.1161/CIRCULATIONAHA.121.054034 |
| work_keys_str_mv | AT felkergmichael implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf AT butlerjaved implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf AT ibrahimnasirene implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf AT pinaileanal implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf AT maiselalan implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf AT bapatdevavrat implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf AT camachoalexander implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf AT wardjonathanh implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf AT williamsonkristinm implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf AT solomonscottd implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf AT januzzijamesl implantablecardioverterdefibrillatoreligibilityafterinitiationofsacubitrilvalsartaninchronicheartfailureinsightsfromprovehf |